Show an ad over header. AMP

I am the FIRST!!!

GoodRx prices IPO at $33 per share, valued at $12.7 billion

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.


  • The company will begin listing Wednesday on the Nasdaq under ticker GDRX, and used Morgan Stanley as lead underwriter.
  • It reports nearly $55 million of net income on $257 million in revenue for the first half of 2020, making it one of precious few profitable tech startups to go public.
  • Existing investor Silver Lake agreed to buy another $100 million of stock via the IPO. Prior to the IPO, Silver Lake had a 35.3% ownership stake.
  • Other investors include Francisco Partners (23.7% pre-IPO stake) and Spectrum Equity (15.4%),

regular 4 post ff

infinite scroll 4 pff

Live updates: Apple details the future of iPhone software at annual developer conference

Apple is set to unveil its latest software for iPhones and Macs as it kicks off its annual Worldwide Developer Conference with a keynote at 10 a.m. PT.

Why it matters: The online-only gathering comes amid growing pressure from developers and regulators for Apple to loosen its tight grip on the App Store and related payment mechanisms.

Check back for live coverage.

“Brink of anarchy”: Netanyahu ignores law to appoint loyalist justice minister

An Israeli cabinet meeting exploded into a shouting match today after Prime Minister Benjamin Netanyahu attempted to install a loyalist as justice minister despite the attorney general’s determination that such a move was illegal.

Why it matters: Netanyahu is on trial for bribery, fraud and breach of trust, and his mandate to form Israel's next government will expire in six days. As his position grows more vulnerable, his critics are accusing him of attempting to subvert Israeli democracy.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;